Cited by 390T-cell and B-cell ImmunologyCancer Immunotherapy and BiomarkersReproductive System and Pregnancy

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Cutting Edge: Molecular Analysis of the Negative Regulatory Function of Lymphocyte Activation Gene-3

Workman, Creg J, Dugger, Kari J, Vignali, Dario A A·2002·The Journal of Immunology

Open this paper in CoChat — free account

Abstract

Lymphocyte activation gene (LAG)-3 (CD223) is a CD4-related activation-induced cell surface molecule that binds to MHC class II molecules with high affinity and negatively regulates T cell expansion and homeostasis. In this study, we show that LAG-3 inhibits CD4-dependent, but not CD4-independent, T cell function via its cytoplasmic domain. Although high affinity interaction with MHC class II molecules is essential for LAG-3 function, tailless LAG-3 does not compete with CD4 for ligand binding. A single lysine residue (K468) within a conserved "KIEELE" motif is essential for interaction with downstream signaling molecules. These data provide insight into the mechanism of action of this important T cell regulatory molecule.

Integrity signals

Registry

Crossref · 10.4049/jimmunol.169.10.5392

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717
LAG-3, a novel lymphocyte activation gene closely related to CD4.
Triebel, F., Jitsukawa, S., Baixerás, E., Roman‐Roman, S., Genevée, C., Viégas-Pèquignot, E., & Hercend, T. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.5.1393 · Cited by 936
Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens.
Baixerás, E., Huard, B., Miossec, C., Jitsukawa, S., Martin, M., Hercend, T., Auffray, C., Triebel, F., & Piatier‐Tonneau, D. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.2.327 · Cited by 397
CD4/major histocompatibility complex class II interaction analyzed with CD4‐ and lymphocyte activation gene‐3 (LAG‐3)‐Ig fusion proteins
Huard, B., Prigent, P., Tournier, M., Bruniquel, D., & Triebel, F. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250949 · Cited by 391
Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: evidence for more than one receptor class.
Gronwald, R. G., Grant, F. J., Haldeman, B. A., Hart, C. E., O’Hara, P. J., Hagen, F. S., Ross, R., Bowen‐Pope, D. F., & Murray, M. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.10.3435 · Cited by 316
Characterization of the major histocompatibility complex class II binding site on LAG-3 protein
Huard, B., Mastrangeli, R., Prigent, P., Bruniquel, D., Donini, S., Tayar, N. E., Maigret, B., Dréano, M., & Triebel, F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.11.5744 · Cited by 308
CD3/TCR complex‐associated lymphocyte activation gene‐3 molecules inhibit CD3/TCR signaling
Hannier, S., Tournier, M., Bismuth, G., & Triebel, F. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.4058 · Cited by 248
Peroxisome proliferator-activated receptor γ activators affect the maturation of human monocyte-derived dendritic cells
Gosset, P., Charbonnier, A.-S., Delerive, P., Fontaine, J., Staels, B., Pestel, J., Tonnel, A., & Trottein, F. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10 · Cited by 225
Retroviral-Mediated Transfer of the Green Fluorescent Protein Gene Into Murine Hematopoietic Cells Facilitates Scoring and Selection of Transduced Progenitors In Vitro and Identification of Genetically Modified Cells In Vivo
Persons, D. A., Allay, J. A., Allay, E. R., Smeyne, R. J., Ashmun, R. A., Sorrentino, B. P., & Nienhuis, A. W. (1997) · Blood · doi:10.1182/blood.v90.5.1777 · Cited by 222
Cellular expression and tissue distribution of the human LAG-3-encoded protein, an MHC class II ligand
Huard, B., Gaulard, P., Faure, F., Hercend, T., & Triebel, F. (1994) · Immunogenetics · doi:10.1007/bf00241263 · Cited by 202
Independent Modes of Natural Killing Distinguished in Mice Lacking Lag3
Miyazaki, T., Dierich, A., Benoist, C. O., & Mathis, D. J. (1996) · Science · doi:10.1126/science.272.5260.405 · Cited by 178
T Cell Receptor Recognition of MHC Class II–Bound Peptide Flanking Residues Enhances Immunogenicity and Results in Altered TCR V Region Usage
Carson, R. T., Vignali, K. M., Woodland, D. L., & Vignali, D. A. A. (1997) · Immunity · doi:10.1016/s1074-7613(00)80360-x · Cited by 175
Self-citation
T cell major histocompatibility complex class II molecules down‐regulate CD4+ T cell clone responses following LAG‐3 binding
Huard, B., Prigent, P., Pagès, F., Bruniquel, D., & Triebel, F. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260533 · Cited by 132
The Majority of Immunogenic Epitopes Generate CD4+ T Cells That Are Dependent on MHC Class II-Bound Peptide-Flanking Residues
Arnold, P. Y., Gruta, N. L. L., Miller, T. J., Vignali, K. M., Adams, P. S., Woodland, D. L., & Vignali, D. A. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.2.739 · Cited by 121
Self-citation
Amino acid residues that flank core peptide epitopes and the extracellular domains of CD4 modulate differential signaling through the T cell receptor.
Vignali, D. A. A., & Strominger, J. L. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.6.1945 · Cited by 103
Self-citation
Direct evidence that a class II molecule and a simple globular protein generate multiple determinants.
Allen, P. M., McKEAN, D. J., Beck, B. N., Sheffield, J. B., & Glimcher, L. H. (1985) · The Journal of Experimental Medicine · doi:10.1084/jem.162.4.1264 · Cited by 82
An Improved Method for Generating Retroviral Producer Clones for Vectors Lacking a Selectable Marker Gene
Persons, D. A., Mehaffey, M. G., Kaleko, M., Nienhuis, A. W., & Vanin, E. F. (1998) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.1998.0184 · Cited by 81
LckBP1, a proline‐rich protein expressed in haematopoietic lineage cells, directly associates with the SH3 domain of protein tyrosine kinase p56lck.
Takemoto, Y., Furuta, M., Li, X., Strong-Sparks, W. J., & Hashimoto, Y. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07346.x · Cited by 79
The MHC class II ligand lymphocyte activation gene-3 is co-distributed with CD8 and CD3–TCR molecules after their engagement by mAb or peptide–MHC class I complexes
Hannier, S., & Triebel, F. (1999) · International Immunology · doi:10.1093/intimm/11.11.1745 · Cited by 72
Mouse CD4 binds MHC class II with extremely low affinity
Weber, S., & Karjalainen, K. (1993) · International Immunology · doi:10.1093/intimm/5.6.695 · Cited by 63
Profound Enhancement of T Cell Activation Mediated by the Interaction Between the TCR and the D3 Domain of CD4
Vignali, D. A. A., & Vignali, K. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1431 · Cited by 53
Self-citation
Genomic organization of the human LAG-3/CD4 locus
Bruniquel, D., Borie, N., & Triebel, F. (1997) · Immunogenetics · doi:10.1007/s002510050332 · Cited by 47
Cloning of Murine LAG-3 by Magnetic Bead Bound Homologous Probes and PCR (GENE-CAPTURE PCR)
Mastrangeli, R., Micangeli, E., & Donini, S. (1996) · Analytical Biochemistry · doi:10.1006/abio.1996.0382 · Cited by 43
Identification of a protein, SPY75, with repetitive helix-turn-helix motifs and an SH3 domain as a major substrate for protein tyrosine kinase(s) activated by Fc epsilon RI cross-linking.
Fukamachi, H., Yamada, N., Miura, T., Kato, T., Ishikawa, M., Gulbins, E., Altman, A., Kawakami, Y., & Kawakami, T. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.2.642 · Cited by 42
Reliable generation and use of MHC class II:γ2aFc multimers for the identification of antigen-specific CD4+ T cells
Arnold, P. Y., Vignali, K. M., Miller, T. B., Gruta, N. L. L., Cauley, L. S., Haynes, L., Adams, P. S., Swain, S. L., Woodland, D. L., & Vignali, D. A. A. (2002) · Journal of Immunological Methods · doi:10.1016/s0022-1759(02)00343-5 · Cited by 28
Self-citation
Phenotypic analysis of the murine CD4-related glycoprotein, CD223 (LAG-3)
(2002) · doi:10.1002/1521-4141(200208)32:8
Self-citation

Research works printed but not linked: 25

1996, Annu. Rev. Immunol, 233
1996, Eur. J. Immunol., 1180
1992, J. Exp. Med., 327
1998, J. Immunol., 4058
1990, J. Exp. Med., 1393
1997, Immunogenetics, 96
1997, Proc. Natl. Acad. Sci. USA, 5744
1994, Immunogenetics, 213
2002, Eur. J. Immunol., 2255
1995, Eur. J. Immunol., 2718
1996, Science, 405
1996, Anal. Biochem., 93
1995, EMBO J., 3403
1994, J. Immunol., 642
1988, Proc. Natl. Acad. Sci. USA, 3435
1999, J. Immunol., 1431
1997, Blood, 1777
1998, Blood Cells Mol. Dis., 167
1985, J. Exp. Med., 1264
1994, J. Exp. Med., 1945
J. Immunol., 739
1997, Immunity, 387
1993, Int. Immunol., 695
2001, Eur. J. Immunol., 2885
1999, Int. Immunol., 1745

Sorted by citations

Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
Wei, S. C., Duffy, C. R., & Allison, J. P. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0367 · Cited by 3,088
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.09.006 · Cited by 2,103
Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation
Anderson, A. C., Joller, N., & Kuchroo, V. K. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.001 · Cited by 2,096
CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer
McLane, L. M., Abdel-Hakeem, M. S., & Wherry, E. J. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055318 · Cited by 2,054
Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
Woo, S.-R., Turnis, M. E., Goldberg, M. V., Bankoti, J., Selby, M., Nirschl, C. J., Bettini, M. L., Gravano, D. M., Vogel, P., Liu, C. L., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1620 · Cited by 1,647
Self-citation

See all 390

Authors: Workman, C. J., Dugger, K. J., & Vignali, D. A. A.
Affiliations: St. Jude Children's Research Hospital (US)
ORCID: Workman, Creg J
Dugger, Kari J
Vignali, Dario A A
Venue: The Journal of Immunology
Publisher: Oxford University Press (OUP)
Published: 2002-11
Volume: 169
Issue: 10
Pages: 5392-5395
ISSN: 0022-1767 (ISSN-L)
1550-6606
DOI: 10.4049/jimmunol.169.10.5392
OpenAlex: W1480698358
Cited by: 389
References: 26
Citations by year: 2026: 18 · 2025: 28 · 2024: 50 · 2023: 41 · 2022: 37 · 2021: 30 · 2020: 38 · 2019: 30 · 2018: 25 · 2017: 17 · 2016: 9 · 2015: 12 · 2014: 3 · 2013: 4 · 2012: 7
FWCI: 1.42
Type: journal article
Language: en
Open access: closed
Licence: academic.oup.com/pages/standard-publication-reuse-rights (vor)
Locations: The Journal of Immunology (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (CA-09346, T32CA009346, CA23944, CA21765, R25CA023944, P30CA021765)
National Institute of Allergy and Infectious Diseases (T32AI007372, AI-07372, AI39480)
Topics: Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
Keywords: LAG-3, T cell regulation, MHC class II binding, cytoplasmic domain, negative regulation of T cell activation
MeSH terms: Lymphocyte Activation Gene 3 Protein, Amino Acid Sequence, Animals, Histocompatibility Antigens Class II, Cytoplasm, Humans, Hybridomas, Ligands, Lymphocyte Activation, Membrane Proteins, Molecular Sequence Data, Tumor Cells, Cultured, Down-Regulation, Antigens, CD, CD4 Antigens, Conserved Sequence, Protein Structure, Tertiary, Amino Acid Motifs, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cutting Edge: Molecular Analysis of the Negative Regulatory Function of Lymphocyte Activation Gene-3

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks